{"id":"W2597591782","doi":"10.1200/jco.2013.31.15_suppl.6552","title":"Cost-effective analysis of the use of EGFR inhibitors (E) for wild-type (WT) KRAS unresectable metastatic colorectal cancer (mCRC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; KRAS; Cetuximab; Colorectal cancer; Internal medicine; Oncology; Irinotecan; Bevacizumab; Cohort; Capecitabine; Oxaliplatin; Cancer; Family medicine; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005477407,0.001108224,0.001572445,0.001779123,0.0003953963,0.001378915,0.001593864,0.001340129,0.00448834],"category_scores_gemma":[0.01646078,0.001041757,0.004431968,0.0009919155,0.0006888559,0.001472257,0.001247936,0.001186927,0.000179486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01296017,"about_ca_system_score_gemma":0.008359442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04764988,"about_ca_topic_score_gemma":0.0355949,"domain_scores_codex":[0.9970378,0.002023979,0.0001179711,0.0001830113,0.0002242783,0.0004129616],"domain_scores_gemma":[0.9888626,0.008043145,0.001794261,0.0002039319,0.00030555,0.0007905759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.02759698,0.00187614,0.04640195,0.001924102,0.00545606,0.0004329722,0.0001216144,0.8755999,0.0006063394,0.005492545,0.001594995,0.03289641],"study_design_scores_gemma":[0.007588735,0.01588899,0.04027751,0.0006786674,0.008672358,0.0004188924,0.0002927652,0.9165263,0.0006540876,0.006008075,0.002879513,0.0001141142],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9669198,0.007137466,0.009211158,0.002433553,0.00009813693,0.00282264,0.004727266,0.00008330115,0.006566738],"genre_scores_gemma":[0.9964161,0.0007142811,0.001479637,0.0001321977,0.00001686557,0.0002782049,0.0005830977,0.000004188579,0.0003753043],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04764988,"threshold_uncertainty_score":0.0947451,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2397591014222592,"score_gpt":0.4231310266491836,"score_spread":0.1833719252269244,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}